Dylan Scott

Either whether they, you know, there's something in their blood or their stool that indicates they may be developing cancer right now, or they can get tested for like their genetic background. And maybe they have just like those sort of built in risks because of their genes. And like, you know, there's blood tests that have been developed that are like really good at catching late stage cancers.

Either whether they, you know, there's something in their blood or their stool that indicates they may be developing cancer right now, or they can get tested for like their genetic background. And maybe they have just like those sort of built in risks because of their genes. And like, you know, there's blood tests that have been developed that are like really good at catching late stage cancers.

Either whether they, you know, there's something in their blood or their stool that indicates they may be developing cancer right now, or they can get tested for like their genetic background. And maybe they have just like those sort of built in risks because of their genes. And like, you know, there's blood tests that have been developed that are like really good at catching late stage cancers.

And now so the next, you know, the next frontier for them is trying to catch early cancers or like pre-cancerous growths. And so I think as those consumer products keep developing, that should allow us to screen more people, screen younger people, and hopefully catch some of these cancers earlier so that we can have better outcomes. And so that's on the diagnostic side.

And now so the next, you know, the next frontier for them is trying to catch early cancers or like pre-cancerous growths. And so I think as those consumer products keep developing, that should allow us to screen more people, screen younger people, and hopefully catch some of these cancers earlier so that we can have better outcomes. And so that's on the diagnostic side.

And now so the next, you know, the next frontier for them is trying to catch early cancers or like pre-cancerous growths. And so I think as those consumer products keep developing, that should allow us to screen more people, screen younger people, and hopefully catch some of these cancers earlier so that we can have better outcomes. And so that's on the diagnostic side.

In terms of treatment, I've been writing about this for 10 years now. There's been a ton of progress with what are called immunotherapies, which is the old way of treating cancer has been We're going to just blast this shit with as much radiation as we can find and hope that that kills the cancer because otherwise we don't know how to do it.

In terms of treatment, I've been writing about this for 10 years now. There's been a ton of progress with what are called immunotherapies, which is the old way of treating cancer has been We're going to just blast this shit with as much radiation as we can find and hope that that kills the cancer because otherwise we don't know how to do it.

In terms of treatment, I've been writing about this for 10 years now. There's been a ton of progress with what are called immunotherapies, which is the old way of treating cancer has been We're going to just blast this shit with as much radiation as we can find and hope that that kills the cancer because otherwise we don't know how to do it.

But it obviously has all of these really terrible side effects. People feel horrible, they lose their hair, whatever. And what we're trying to do now with these immunotherapies is like, let's remove radiation and all this chemical nastiness from the equation. Let's like train the body's immune system to fight these cancers on its own.

But it obviously has all of these really terrible side effects. People feel horrible, they lose their hair, whatever. And what we're trying to do now with these immunotherapies is like, let's remove radiation and all this chemical nastiness from the equation. Let's like train the body's immune system to fight these cancers on its own.

But it obviously has all of these really terrible side effects. People feel horrible, they lose their hair, whatever. And what we're trying to do now with these immunotherapies is like, let's remove radiation and all this chemical nastiness from the equation. Let's like train the body's immune system to fight these cancers on its own.

A lot of the improvements that we have seen to cancer prognoses, especially among older people, has been because we're developing these immunotherapies that are teaching the body how to fight the cancer by itself. And then when you combine things like

A lot of the improvements that we have seen to cancer prognoses, especially among older people, has been because we're developing these immunotherapies that are teaching the body how to fight the cancer by itself. And then when you combine things like

A lot of the improvements that we have seen to cancer prognoses, especially among older people, has been because we're developing these immunotherapies that are teaching the body how to fight the cancer by itself. And then when you combine things like

Genetic sequencing, like cancer, we talk about cancer as like one thing, but it's actually like, you know, thousands upon thousands of different diseases and being able to identify like, okay, we know you have like a tumor in your colon, but if we can test it genetically and figure out exactly what type of colon cancer it is, then we can get you, make sure we get you the exact right therapy that, you know, has these proteins or whatever that can better target that cancer.

Genetic sequencing, like cancer, we talk about cancer as like one thing, but it's actually like, you know, thousands upon thousands of different diseases and being able to identify like, okay, we know you have like a tumor in your colon, but if we can test it genetically and figure out exactly what type of colon cancer it is, then we can get you, make sure we get you the exact right therapy that, you know, has these proteins or whatever that can better target that cancer.

Genetic sequencing, like cancer, we talk about cancer as like one thing, but it's actually like, you know, thousands upon thousands of different diseases and being able to identify like, okay, we know you have like a tumor in your colon, but if we can test it genetically and figure out exactly what type of colon cancer it is, then we can get you, make sure we get you the exact right therapy that, you know, has these proteins or whatever that can better target that cancer.

So I don't know fully what's in the hearts of the Trump administration. But what I can say is that the last time around, they proposed very serious cuts to foreign aid. None of them passed Congress, but this was a very consistent proposal during Trump's first term.

So I don't know fully what's in the hearts of the Trump administration. But what I can say is that the last time around, they proposed very serious cuts to foreign aid. None of them passed Congress, but this was a very consistent proposal during Trump's first term.